Parkwalk Advisors

cb Email

Status

ACTIVE

Global HQ

London, United Kingdom

Countries of investment

United Kingdom

Investment stages

Pre-Seed
Seed
Series A

Industries

MedTech
Biotechnology
Deep Tech

About
Parkwalk Advisors specializes in identifying and backing university spinouts from the UK, particularly those commercializing advanced scientific research. Their approach centers on providing capital to early-stage, deep-tech companies that are founded on solid intellectual property developed within prestigious academic institutions. Parkwalk works closely with founders to help them transition from academic research into scalable commercial ventures, supporting them through critical early-stage development to ensure their technologies can reach the market effectively and efficiently.

Min check size: $25K
Max check size: $20M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Parkwalk Advisors strategically focuses on investing in university spinouts that leverage breakthrough academic research to build scalable, defensible deep-tech businesses. The firm’s thesis centers on the long-term potential of science-based innovation emerging from the UK’s top universities. By investing at early stages through EIS funds, Parkwalk seeks to bridge the gap between academia and commercialization—transforming world-class intellectual property into market-leading enterprises. The firm believes that early exposure to IP-rich sectors like life sciences, quantum technologies, and advanced engineering provides both societal and economic returns.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Founded by experienced investment professionals with decades in venture and private equity, focused on early-stage technology and healthcare companies.